JDRF T1D Fund — Full Portfolio

vTv Therapeutics is a biopharmaceutical company developing oral, small molecule drugs for diabetes and other chronic diseases.

BiotechDigital HealthMedical DevicesHigh Point, US

Rudy Howard(Executive Officer)Paul Meister(Director)Stephen Holcombe(Executive Officer)Paul Savas(Director)Noel Spiegel(Director)Howard Weiner(Director)

Aera Therapeutics develops genetic medicines using next-generation delivery technologies and precision payloads optimized for specific diseases.

AI & Machine LearningBiotechDeep TechMedical Devices

Akin Akinc, Ph.D.(CEO)

Aspect Bio Systems develops bioprinted tissue therapeutics for regenerative medicine using a platform that combines AI-powered bioprinting, computational design, therapeutic cells, and biomaterials.

AI & Machine LearningBiotechDeep Tech

Digital HealthHealthtechMedical DevicesNew York, US

Jeffrey Brewer(Executive Officer, Director)Bryan Mazlish(Executive Officer, Director)Jon Brilliant(Executive Officer)

Biolinq develops a non-invasive glucose sensor that uses light to display glucose levels in real time, while also tracking activity and sleep to provide personalized health insights via a mobile app.

BiotechDigital HealthHealthtechMedical DevicesSan Diego, US

Richard Yang(Executive Officer, Director)Edward Kliphuis(Director)Jared Tangney(Executive Officer, Director, Promoter)

BoardDaniel Bradbury(Director)Lana Ghanem(Director)

COUR develops targeted therapies for autoimmune diseases using an antigen-specific platform technology designed to restore immune tolerance while preserving normal immune function.

BiotechHealthtechMedical Devices

Diasome develops the Hepatocyte-Directed Vesicle (HDV) platform to deliver drugs to the liver's portal-hepatic region for improved metabolic control.

BiotechHealthtechMedical Devices

DiogenX is a preclinical-stage biotech company developing biologic therapeutics aimed at restoring insulin-producing beta cells for people with Type 1 diabetes.

BiotechDeep TechDigital HealthHealthtechMarseille, FR

Benjamin Charles(Co-Founder & CEO)Patrick Collombat(Co-Founder & Scientific Advisor)Jean-Pascal Tranié(Co-Founder)

Egle Therapeutics develops targeted immunotherapy drugs by leveraging regulatory T cell (Treg) biology to treat autoimmune diseases and cancer.

Biotech

Michel Detheux(Chairman)Fiorella Kotsias(Chief Scientific Officer)Bernard Vanhove(Chief Development Officer)

Eledon develops tegoprubart, an anti-CD40L antibody in clinical development for preventing rejection in organ transplant recipients.

BiotechMedical Devices

Steven Perrin(President and Chief Scientific Officer)

GentiBio develops engineered T-regulatory cells (Tregs) as allogeneic therapeutics for autoimmune and inflammatory diseases.

BiotechHealthtechMedical Devices

Imtherapeutics develops oral therapies for Type 1 diabetes patients with specific genetic markers.

Biotech

Jaguar Gene Therapy develops gene therapy treatments for severe genetic diseases, focusing on AAV-based platform therapies designed to deliver one-time, long-lasting treatments.

BiotechHealthtechMedical Devices

Biopharmaceutical gene therapy company developing gene therapies intended to be accessible broadly rather than to a limited few.

BiotechMorrisville, US

Ilan Oren(Director)Shankar Ramaswamy(Executive Officer, Director)Michele Stone(Executive Officer)Katherine Eade(Executive Officer)Britt Petty(Executive Officer)Daniel Chen(Executive Officer)

Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments.

BiotechMedical Devices

Mark Davis(Scientific Co-Founder)K. Christopher Garcia(Scientific Co-Founder)Calvin Kuo(Scientific Co-Founder)Katie Fanning(President & Chief Executive Officer)

Protomer engineers responsive biotherapeutics that sense molecular activators in the body using its proprietary Molecular Evolution of Peptide Sensors (MEPS) platform.

BiotechMedical DevicesPasadena, US

Sanofi develops breakthrough medicines and vaccines by applying deep understanding of the immune system.

BiotechHealthtechMedical Devices

SAB BIO develops disease-modifying therapeutics for Type 1 Diabetes that target the underlying autoimmune causes rather than managing symptoms.

BiotechDigital HealthMedical Devices

Sana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.

BiotechHealthtechMedical DevicesSeattle, US

Steve Harr(President and Chief Executive Officer)

Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases.

BiotechHealthtechMedical DevicesSouth San Francisco, US

Fan Yu(Director)Maggie Wilderotter(Director)Toni Hoover(Director)Terry Rosen(Director)Richard Klausner(Director)Jeffrey Bluestone(Executive Officer, Director, Promoter)

Biotech